abiraterone acetate 250 MG Oral Tablet

1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablets are a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). ( 1 ) metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 )

apotex corp.

FDA Reported Adverse Reactions
`[1] nausea` `[2] off label use` `[3] fatigue` `[4] drug ineffective` `[5] diarrhoea` `[6] vomiting` `[7] pain` `[8] dyspnoea` `[9] headache` `[10] pyrexia`

3 years ago

OVAL WHITE APO A250

16 HOW SUPPLIED/STORAGE AND HANDLING

ABIRATERONE ACETATE 250 mg tablets, USP are white to off-white, oval, biconvex uncoated tablets. Engraved "A250" on one side, "APO" on the other side.

ABIRATERONE ACETATE 250 mg tablets, USP are available in high-density polyethylene bottles of 120. Bottle of 120 tablets NDC Number 60505-4327-1 Storage and Handling Store at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Keep out of reach of children. Based on its mechanism of action,

ABIRATERONE ACETATE may harm a developing fetus. Women who are pregnant or women who may be pregnant should not handle

ABIRATERONE ACETATE 250 mg uncoated tablets or other

ABIRATERONE ACETATE tablets if broken, crushed, or damaged without protection, e.g., gloves [see Use in Specific Populations ( 8.1 )] .

More pills like OVAL APO A250

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

abiraterone acetate 250 MG Oral Tablet

FDA Reported Adverse Reactions [1] nausea [2] off label use [3] fatigue [4] drug ineffective [5] diarrhoea [6] vomiting [7] pain [8] dyspnoea [9] headache [10] pyrexia

OVAL WHITE APO A250

More pills like OVAL APO A250

FDA Reported Adverse Reactions
`[1] nausea` `[2] off label use` `[3] fatigue` `[4] drug ineffective` `[5] diarrhoea` `[6] vomiting` `[7] pain` `[8] dyspnoea` `[9] headache` `[10] pyrexia`